Please login to the form below

Not currently logged in


This page shows the latest pertuzumab news and features for those working in and with pharma, biotech and healthcare.

Biosimilar Herceptin helps Roche gain new Perjeta recommendation

Biosimilar Herceptin helps Roche gain new Perjeta recommendation

considerably. The cost effectiveness watchdog has today recommended Roche’s newer breast cancer treatment Perjeta (pertuzumab) in people with early HER2-positive breast cancer whose disease has spread to their lymph ... The NICE document indicates this

Latest news

More from news
Approximately 6 fully matching, plus 48 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...